64,807 Shares in InfuSystem Holdings, Inc. $INFU Bought by CM Wealth Advisors LLC

CM Wealth Advisors LLC purchased a new stake in InfuSystem Holdings, Inc. (NYSE:INFUFree Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 64,807 shares of the company’s stock, valued at approximately $625,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. BlackRock Inc. acquired a new position in InfuSystem during the second quarter valued at approximately $15,299,000. Deutsche Bank AG bought a new stake in shares of InfuSystem during the 2nd quarter worth approximately $185,000. Diamond Hill Capital Management LLC Investment Advisor acquired a new stake in shares of InfuSystem in the 2nd quarter valued at approximately $4,719,000. Bank of New York Mellon Corp bought a new position in shares of InfuSystem in the second quarter valued at $995,000. Finally, GSA Capital Partners LLP acquired a new position in InfuSystem during the second quarter worth $1,548,000. 71.13% of the stock is owned by institutional investors.

Analyst Ratings Changes

Separately, B. Riley Financial reiterated a “buy” rating and issued a $20.00 price target (up from $12.00) on shares of InfuSystem in a research note on Wednesday, August 5th. Three investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $16.67.

Read Our Latest Stock Analysis on INFU

InfuSystem Stock Performance

INFU opened at $12.19 on Thursday. The company has a quick ratio of 1.59, a current ratio of 1.98 and a debt-to-equity ratio of 0.50. InfuSystem Holdings, Inc. has a 12-month low of $7.29 and a 12-month high of $12.97. The business has a 50 day moving average of $10.05 and a 200-day moving average of $9.48. The stock has a market cap of $246.02 million, a price-to-earnings ratio of 203.20 and a beta of 1.42.

InfuSystem announced that its Board of Directors has approved a stock repurchase program on Tuesday, May 19th that authorizes the company to buyback $20.00 million in shares. This buyback authorization authorizes the company to reacquire up to 10.2% of its shares through open market purchases. Shares buyback programs are generally a sign that the company’s board believes its stock is undervalued.

InfuSystem Company Profile

(Free Report)

InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.

In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.

Read More

Want to see what other hedge funds are holding INFU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for InfuSystem Holdings, Inc. (NYSE:INFUFree Report).

Institutional Ownership by Quarter for InfuSystem (NYSE:INFU)

Receive News & Ratings for InfuSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem and related companies with MarketBeat.com's FREE daily email newsletter.